Saliva substitutes for the treatment of radiation-induced xerostomia--a review
- PMID: 19495809
- DOI: 10.1007/s00520-009-0671-x
Saliva substitutes for the treatment of radiation-induced xerostomia--a review
Abstract
Goal: The aim of this review is to summarize the in vitro and in vivo evidence on the performance of contemporary saliva substitutes in the treatment of xerostomia and hyposalivation caused by radiation therapy for head and neck malignancies.
Methods: A literature search was conducted during July to September 2008 in PubMed, using the query terms "saliva substitute", "saliva substitute and xerostomia", "artificial saliva", and "artificial saliva and xerostomia"; for clinical studies, only studies in patients suffering from radiation-induced xerostomia have been included in the review.
Results and conclusion: Fifty-two studies met the inclusion criteria and were allotted either to the in vitro topics "viscosity", "lubrication", "wetting properties", "antimicrobial effects", and "enamel and dentin de- and remineralization", or to the in vivo topics "clinical acceptance" or "influence on plaque formation and oral mucosa and microflora". The findings suggest that there are significant differences in the performance of various saliva substitutes concerning the review parameters, yet indicate that further in vitro and in vivo studies on the properties of saliva substitutes are necessary.
Similar articles
-
[Use of saliva substitutes in patients with xerostomia].Schweiz Monatsschr Zahnmed. 2002;112(10):1037-58. Schweiz Monatsschr Zahnmed. 2002. PMID: 12442709 Review. French, German.
-
A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.J Oral Rehabil. 2017 Nov;44(11):889-895. doi: 10.1111/joor.12545. Epub 2017 Aug 20. J Oral Rehabil. 2017. PMID: 28741683 Clinical Trial.
-
Design of a randomized controlled double-blind crossover clinical trial to assess the effects of saliva substitutes on bovine enamel and dentin in situ.BMC Oral Health. 2011 Apr 9;11:13. doi: 10.1186/1472-6831-11-13. BMC Oral Health. 2011. PMID: 21477333 Free PMC article. Clinical Trial.
-
Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).Int J Pharm. 2018 Apr 25;541(1-2):157-166. doi: 10.1016/j.ijpharm.2018.02.004. Epub 2018 Feb 6. Int J Pharm. 2018. PMID: 29425763 Review.
-
Saliva substitutes: how effective and safe are they?Oral Dis. 2002 Jul;8(4):177-9. doi: 10.1034/j.1601-0825.2002.02848.x. Oral Dis. 2002. PMID: 12206397 No abstract available.
Cited by
-
Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.Clin Oral Investig. 2011 Apr;15(2):127-39. doi: 10.1007/s00784-010-0450-6. Epub 2010 Sep 22. Clin Oral Investig. 2011. PMID: 20859645
-
Using mid infrared technology as new method for the determination of the dwell time of salivary substitutes on three dimensional gingiva models.BMC Ear Nose Throat Disord. 2016 Mar 15;16:6. doi: 10.1186/s12901-016-0025-5. eCollection 2016. BMC Ear Nose Throat Disord. 2016. PMID: 26985168 Free PMC article.
-
Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study.PLoS One. 2016 Mar 31;11(3):e0152817. doi: 10.1371/journal.pone.0152817. eCollection 2016. PLoS One. 2016. PMID: 27031997 Free PMC article.
-
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.Cancer Treat Rev. 2024 Jun;127:102748. doi: 10.1016/j.ctrv.2024.102748. Epub 2024 Apr 30. Cancer Treat Rev. 2024. PMID: 38703593 Free PMC article. Review.
-
Saliva substitutes in combination with high-fluoride gel on dentin remineralization.Clin Oral Investig. 2015 Mar;19(2):289-97. doi: 10.1007/s00784-014-1264-8. Epub 2014 May 29. Clin Oral Investig. 2015. PMID: 24872322
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous